RollingStone Co., Ltd. (KOSDAQ:214610)
3,240.00
-130.00 (-3.86%)
At close: Feb 13, 2026
RollingStone Market Cap
RollingStone has a market cap or net worth of 27.14 billion as of February 13, 2026. Its market cap has decreased by -55.37% in one year.
Market Cap
27.14B
Enterprise Value
19.78B
Revenue
891.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,240.00
Market Cap Chart
Since April 5, 2017, RollingStone's market cap has decreased from 43.12B to 27.14B, a decrease of -37.07%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 27.14B | -10.12% |
| Dec 30, 2025 | 30.20B | -50.38% |
| Dec 30, 2024 | 60.85B | -24.58% |
| Dec 28, 2023 | 80.68B | -8.17% |
| Dec 29, 2022 | 87.86B | -47.23% |
| Dec 30, 2021 | 166.50B | -18.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JPI Healthcare | 75.05B |
| Hironic | 74.74B |
| DRGEM | 59.49B |
| Neofect | 58.49B |
| Genoray | 54.42B |
| UXN Co., Ltd. | 40.45B |
| CU Medical Systems | 35.53B |
| Genesystem | 33.56B |